Canada to Lift Flavor Ban on E-Cigarettes After 3 Years

Regulations by 2FIRSTS.ai
Apr.12.2024
Canada to Lift Flavor Ban on E-Cigarettes After 3 Years
Canada to lift 3-year flavor ban on e-cigarettes, requiring manufacturers to use approved ingredients, sparking backlash from consumers.

According to a report by Vaping360 on April 11th, Canada will lift the 3-year-old ban on flavored e-cigarettes. The ban was initially approved by the government in June 2021 but has been dormant ever since.

 

According to the regulation, Health Canada will provide manufacturers with a list of up to 100 permitted flavoring ingredients and mandate that only these ingredients can be used to make e-liquid, but only for tobacco, menthol, and mint flavors.

 

At the same time, the use of any type of sweeteners is strictly prohibited. The agency stated in 2021 that an estimated 80-85% of existing products will need to be reformulated to meet the new requirements. Additionally, the regulation will specify "sensory attribute standards to prevent sensations other than those typical of tobacco or mint/menthol from being perceived." In other words, manufacturers will not be able to add caramel to tobacco flavors, or fruit flavors to mint flavors.

 

Five provinces in Canada have already banned flavored e-cigarettes. Quebec has been enforcing the ban since last October, while New Brunswick, Nova Scotia, the Northwest Territories, and Prince Edward Island have implemented similar regulations. Nunavut has also passed the ban, but has not yet set a specific implementation date. However, despite these flavor bans being in place, over 70% of Canadians can still purchase flavored e-cigarettes.

 

Canadian Health Minister Mark Holland is vigorously pushing to lift the long-standing ban, with support from the Heart and Stroke Foundation, the Canadian Cancer Society, the Canadian Lung Association, and some smaller anti-tobacco non-governmental organizations.

 

During a recent press conference, Holland stated: "I have previously collaborated with the Heart and Stroke Foundation to address the issue of e-cigarettes. At that time, when the information was uncertain, they advised that e-cigarettes be seen as a smoking cessation tool rather than taking action. Unfortunately, this led to the tobacco industry attracting a group of young people who had never been exposed to nicotine to something that threatens their health. This has had extremely adverse consequences for our healthcare system." Canadian e-cigarette consumers have expressed that the ban will have a destructive impact on the legal consumption of e-cigarettes and will cause irreversible harm to the independent e-cigarette industry. Canada has around 1.8 million e-cigarette users, with the majority preferring flavors that are not permitted by the health department. The proposed regulations will force many people to return to smoking and create a vibrant disposable e-cigarette "black market.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Juul Wins UK Court Injunction, Ending Five-Year Legal Battle Against Chinese Vape Infringers
Juul Wins UK Court Injunction, Ending Five-Year Legal Battle Against Chinese Vape Infringers
The UK High Court has granted U.S. e-cigarette manufacturer Juul Labs a permanent injunction against four Chinese companies, bringing an end to a five-year patent and trademark infringement case. The defendants — Greensun Technology, Ouch, Gaish, and Airsmo Tech — failed to respond to any court communications or legal filings.
Oct.30 by 2FIRSTS.ai
Lawmakers Push to Include E-Cigarettes in Vietnam’s Revised Investment Law Ban
Lawmakers Push to Include E-Cigarettes in Vietnam’s Revised Investment Law Ban
Vietnam’s National Assembly has debated amendments to the Investment Law that would include e-cigarettes, heated tobacco, and nitrous oxide (N₂O) in the list of prohibited business activities. Lawmakers supported a total ban consistent with WHO recommendations and previous National Assembly resolutions, citing rising youth addiction rates. Finance Minister Nguyễn Văn Thắng confirmed that the ban would apply comprehensively, with a short transition period for foreign factories.
Nov.27 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”
Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”
Philip Morris Bangladesh Limited (PMBL) has received approval to invest USD 5.82 million in a nicotine pouch factory in Narayanganj. Regulators say the project is legal under existing laws, while health groups argue it breaches a 2016 Supreme Court order and poses youth addiction risks.
Nov.07 by 2FIRSTS.ai
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.
Nov.14 by 2FIRSTS.ai
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21